Protection by antibiotics against myeloperoxidase-dependent cytotoxicity to lung epithelial cells in vitro.
Myeloperoxidase, in the presence of noncytotoxic concentrations of H2O2, was used to induce cytotoxicity to the lung epithelial cell line, AKD. When the cationic aminoglycosides, tobramycin and gentamicin were added to the cells in the presence of myeloperoxidase and H2O2, cytotoxicity was completely inhibited. In addition, tobramycin prevented cytotoxicity induced by cystic fibrosis sputum and H2O2. Protection against myeloperoxidase and H2O2 was also observed with the thioether-containing antibiotics, ticarcillin and ceftazidime, but at higher concentrations than with the aminoglycosides. Analysis of spectral properties, dimethylsulfoxide-mediated reduction, and ethyl acetate/NaCl partitioning, demonstrated that aminoglycosides converted HOCl to hydrophilic noncytotoxic chloramines, but were unable to prevent the oxidation of sulfhydryls and methionine by HOCl. In contrast, ticarcillin and ceftazidime were highly effective inhibitors of HOCl-mediated sulfhydryl and methionine oxidation. These results suggest that aminoglycosides protect lung epithelial cells against myeloperoxidase-dependent oxidant injury by binding to anionic cell surfaces and converting HOCl to hydrophilic noncytotoxic chloramines, whereas penicillins and cephalosporins are potent HOCl scavengers capable of protecting critical extracellular molecules against oxidation.
Unité de Recherche Pulmonaire, Centre Hospitalier Universitaire de Sherbrooke, Quebec, Canada.
A
A
Cantin
D E
DE
Woods
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002374:Catalase / Q000494:pharmacology; D002415:Cats; D002442:Ceftazidime / Q000494:pharmacology; D002470:Cell Survival / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D004847:Epithelial Cells; D004848:Epithelium / Q000187:drug effects; D005839:Gentamicins / Q000494:pharmacology; D005978:Glutathione / Q000494:pharmacology; D006098:Granulocytes / Q000201:enzymology; D006801:Humans; D007700:Kinetics; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000097:blood / Q000201:enzymology; D008168:Lung; D008715:Methionine / Q000494:pharmacology; D009195:Peroxidase / Q000097:blood / Q000302:isolation & purification / Q000494:pharmacology*; D012973:Sodium Hypochlorite / Q000494:pharmacology; D013329:Structure-Activity Relationship; D013982:Ticarcillin / Q000494:pharmacology; D014031:Tobramycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D002442:Ceftazidime; D008715:Methionine; D012973:Sodium Hypochlorite; D002374:Catalase; D009195:Peroxidase; D013982:Ticarcillin; D005978:Glutathione; D014031:Tobramycin